Cleveland BioLabs Analysis

Cleveland BioLabs is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Cleveland BioLabs delisted stock analysis is to determine its intrinsic value, which is an estimate of what Cleveland BioLabs is worth, separate from its market price. There are two main types of Cleveland BioLabs' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Cleveland BioLabs' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Cleveland BioLabs' stock to identify patterns and trends that may indicate its future price movements.
The Cleveland BioLabs stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Cleveland BioLabs is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Cleveland Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Cleveland BioLabs' ongoing operational relationships across important fundamental and technical indicators.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Cleveland Stock Analysis Notes

About 50.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.18. Cleveland BioLabs last dividend was issued on the 29th of October 2010. The entity had 1:20 split on the 28th of January 2015. Cleveland BioLabs, Inc., a biopharmaceutical company, develops novel approaches to activate the immune system and address various medical needs in the United States and Russia. The company was incorporated in 2003 and is headquartered in Buffalo, New York. Cleveland Biolabs operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 2 people. For more info on Cleveland BioLabs please contact Yakov Kogan at 716 849-6810 or go to www.cbiolabs.com.

Cleveland BioLabs Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Cleveland BioLabs' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Cleveland BioLabs or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Cleveland BioLabs is not yet fully synchronised with the market data
Cleveland BioLabs has some characteristics of a very speculative penny stock
Cleveland BioLabs has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 106.9 K. Net Loss for the year was (2.35 M) with loss before overhead, payroll, taxes, and interest of (428.13 K).
Cleveland BioLabs currently holds about 14.62 M in cash with (2.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.94.
Roughly 50.0% of the company shares are held by company insiders

Cleveland Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 49.04 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cleveland BioLabs's market, we take the total number of its shares issued and multiply it by Cleveland BioLabs's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Cleveland BioLabs to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Premium Stories Now

   

Premium Stories

Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
All  Next Launch Module
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Consideration for investing in Cleveland Stock

If you are still planning to invest in Cleveland BioLabs check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cleveland BioLabs' history and understand the potential risks before investing.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format